Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Harmony Biosciences

Explore full profile

Biopharmaceutical company and a member of the Paragon Biosciences corporate family

Upper Merion Township, United StatesFounded 2017Biotech & Life Sciences
Valuation $1.56B Market cap · 2026
Revenue $1.02B Latest reported FY
EBITDA $297M Latest reported FY
Total funding $100–500M Disclosed equity funding

About Harmony Biosciences

Harmony Biosciences is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases. The company operates in the healthcare sector, specifically targeting conditions that have limited treatment options. Harmony Biosciences serves patients, healthcare providers, and the broader medical community by bringing breakthrough science within reach. The business model revolves around the research, development, and commercialization of novel medications, generating revenue through the sale of these specialized therapies. The company invests heavily in scientific research to identify new clinical possibilities and advance the treatment landscape for rare neurological disorders.

Source: Dealroom company data

At a glance

Founded
2017
Headquarters
Upper Merion Township, United States
Listing
IPO 2020
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Harmony Biosciences.

See all news

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later13 investors entered at this stage

Talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States99.6%
🇮🇳 India0.4%
2 countries shown
Web traffic by country
7.1K monthly visits
across markets
🇺🇸 United States69%
🇮🇳 India23.9%
🇧🇩 Bangladesh2.8%
🇬🇧 United Kingdom2.8%
🇧🇷 Brazil1.4%
Top 5 markets shown

Patents

Estimated portfolio value
$55M

32 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Harmony Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Harmony Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles